Mary Lucus
Nessuna posizione attualmente
Profilo
Mary Christine Lucus served as the Chief Financial Officer, Secretary & Controller at Selectis Health, Inc. from 2022 to 2023.
Prior to that, she worked as a Controller at NeuBase Therapeutics, Inc. Ms. Lucus received an undergraduate degree from San Diego State University.
Precedenti posizioni note di Mary Lucus
Società | Posizione | Fine |
---|---|---|
SELECTIS HEALTH, INC. | Direttore Finanziario/CFO | 05/04/2023 |
NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Formazione di Mary Lucus
San Diego State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SELECTIS HEALTH, INC. | Finance |
Aziende private | 1 |
---|---|
NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on March 29, 2002 and is headquartered in Pittsburgh, PA. | Health Technology |
- Borsa valori
- Insiders
- Mary Lucus